A trial of osimertinib for non small cell lung cancer (AURA3) | Cancer Research UK
Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC | Scientific Reports
AURA3 Clinical Study Data – TAGRISSO® (osimertinib)
Osimertinib in Pretreated T790M-Positive Advanced Non–Small-Cell Lung Cancer: AURA Study Phase II Extension Component | Journal of Clinical Oncology
Characterization of a Real-World Response Variable and Comparison with RECIST-Based Response Rates from Clinical Trials in Advanced NSCLC | SpringerLink
Dihydroergotamine for Migraine Clinical Trial 2022 | Power
AURA3 Clinical Study Data – TAGRISSO® (osimertinib)
AURA3 Clinical Study Data – TAGRISSO® (osimertinib)
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer | NEJM
Patient-reported symptoms possibly related to treatment with osimertinib or chemotherapy for advanced non-small cell lung cancer - Lung Cancer
Osimertinib (AZD9291)—a science-driven, collaborative approach to rapid drug design and development - Annals of Oncology
Osimertinib versus osimertinib plus chemotherapy for non–small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial - European Journal of Cancer
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer | NEJM
d.planchard on Twitter: "Important result awaiting in EGFR mut pts :OS of AURA3 trial : just confirm to use osimertinib first line @myESMO #esmoasia19 https://t.co/Dwh04T0C4N" / Twitter
Osimertinib versus Standard of Care EGFR TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC: FLAURA Asian Subset - Journal of Thoracic Oncology
Tagrisso demonstrates superiority over chemotherapy in EGFR T790M mutation-positive non-small cell lung cancer
Clinical Trials with Osimertinib | Download Scientific Diagram
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis - ScienceDirect
Frontiers | Patterns and Treatment Strategies of Osimertinib Resistance in T790M-Positive Non-Small Cell Lung Cancer: A Pooled Analysis
Aurinia And Voclosporin In Lupus Nephritis: The Countdown Begins (NASDAQ:AUPH) | Seeking Alpha
Tagrisso demonstrates superiority over chemotherapy in EGFR T790M mutation-positive non-small cell lung cancer
